Hand/foot
SHEILA -
Gosh I am sorry that after so much time you did develope the hand/foot horror.
Mine started right away when I started on the Xeloda and we had to reduce dosage from 3000mg to 2650mg.
My fingers are all cracked now and those tiny little cracks that look like nothing sure do hurt. My feet are always a mess. I don't think I have worn closed in shoes for years now. Good thing I live in Florida. I think this is why I got such a HUGE blister on the bottom of one of my feet because my skin was already so sensitive.
I am going to ask my doctor about that Biofine Ointment to see if that works better then everything I have tried.
Unfortunately, the side effects of some of these drugs are difficult to deal with. I keep telling myself that it is better then getting nausea, which I never have thank goodness, but we do have to walk and use our hands a lot so it makes it difficult none the less.
Sheila - we are just going to have to relax more and have others wait on us huh? lol
Take care and hope your issues get resolved.
__________________
Irene from Tampa
1996 - INFILT DUCTAL CAR.W/ LYMPH NODE INVOLVEMENT. ADRIA/CYTOXIN/5FU
1999 - RECURR. TO AUXILA AND 2 TUMORS IN LIVER
TREAT: STEM CELL REPLACEMENT/HERCEPTIN.
2002 - RECUR TO LIVER
TREAT: NAVELBINE, THEN GEMZAR, THEN XELODA.
2004 - TUMORS STILL IN LIVER
TREAT: RFA TO LIVER
STABLE UNTIL
2004 - TUMOR PROGRESSION IN LIVER.
TREAT: RESECT HALF OF LIVER.
2005 - RECURR TO LYMPH NODE OUTSIDE OF LIVER.
TREAT: TAXOL/CARPO/HERCEPTIN. FAILED ON
THIS TRIO. STARTED ON ABRAXANE.
2006 - PROGRESS WITH 2ND TUMOR GROWTH.
TREAT: AUG. BEGAN ON TYKERB/XELODA
TRIAL. CONSIDERED STABLE TO DATE.
2007 - TAKEN OFF OF TYKERB/XELODA TRIAL DUE TO
PROGRESS STARTING TYKERB/AVASTIN.
NOV 2007 - SCANS SHOW PROGRESS TUMOR GROWTH
IN ABDOM. AND TWO NEW TUMORS IN NECK AREA.
BEGAN HERCEPTIN/AVASTIN/TAXOTERE
Feb 08 - Ixempra/Xeloda
June 08 - Her/DM1 trial
"I WANT TO BE AN OUTRAGEOUS OLD WOMAN WHO NEVER GETS CALLED AN OLD LADY. I WANT TO GET SHARP EDGED & EARTH COLORED, TILL I FADE AWAY FROM PURE JOY."
|